Stock listing
NASDAQ:TIL Instil Bio, Inc. Stock
Home listing (NASDAQ) of Instil Bio, Inc.
Follow Instil Bio, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TIL
$5.23 USD -0.20 (-3.7%)
Close on Nov 20, 2026
- Day range
- $5.20 – $5.65 USDNov 20, 2026
- Volume
- 64,336 sharesNov 20, 2026
- Market cap
- $35.47M USDAt the close on Nov 20, 2026 · price × 6.78M shares outstanding
- 52-week range
- $5.14 – $13.50 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $256,706 USDMedian day 25,173 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TIL · Home | $5.23 USD | -0.20 (-3.7%) | 64,336 | $5.45 | $5.65 | $5.20 | $5.43 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TIL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.23 | -0.20 | -3.7% | $5.45 | $5.65 | $5.20 | 64,336 | |
| $5.43 | +0.03 | +0.6% | $5.36 | $5.63 | $5.33 | 119,802 | |
| $5.40 | -0.35 | -6.1% | $5.64 | $5.73 | $5.14 | 164,635 | |
| $5.75 | -0.33 | -5.4% | $6.02 | $6.075 | $5.28 | 138,888 | |
| $6.08 | -0.16 | -2.6% | $6.202 | $6.495 | $6.02 | 51,629 | |
| $6.24 | -0.07 | -1.1% | $6.33 | $6.63 | $6.10 | 96,317 | |
| $6.31 | -0.04 | -0.6% | $6.35 | $6.60 | $6.23 | 53,338 | |
| $6.35 | -0.12 | -1.9% | $6.42 | $6.86 | $6.343 | 22,727 | |
| $6.47 | -0.36 | -5.3% | $6.81 | $6.99 | $6.38 | 32,674 | |
| $6.83 | -0.16 | -2.3% | $6.72 | $6.98 | $6.30 | 107,046 | |
| $6.99 | 0.00 | 0.0% | $6.85 | $7.125 | $6.70 | 92,543 | |
| $6.99 | +0.32 | +4.8% | $6.74 | $7.10 | $6.596 | 75,590 | |
| $6.67 | +0.12 | +1.8% | $6.745 | $6.805 | $6.60 | 25,281 | |
| $6.55 | -0.25 | -3.7% | $6.73 | $6.91 | $6.51 | 33,865 | |
| $6.80 | -0.025 | -0.4% | $6.74 | $6.87 | $6.51 | 25,228 | |
| $6.825 | +0.035 | +0.5% | $6.71 | $7.12 | $6.71 | 57,660 | |
| $6.79 | +0.95 | +16.3% | $5.85 | $6.93 | $5.85 | 149,610 | |
| $5.84 | +0.27 | +4.8% | $5.56 | $6.08 | $5.56 | 102,053 | |
| $5.57 | -0.27 | -4.6% | $5.86 | $5.88 | $5.57 | 36,689 | |
| $5.84 | +0.14 | +2.5% | $5.76 | $5.90 | $5.66 | 121,348 | |
| $5.70 | -0.07 | -1.2% | $5.80 | $5.94 | $5.68 | 84,883 | |
| $5.77 | -0.17 | -2.9% | $6.01 | $6.09 | $5.73 | 40,868 | |
| $5.94 | +0.15 | +2.6% | $5.88 | $6.19 | $5.85 | 100,161 | |
| $5.79 | -0.12 | -2.0% | $5.89 | $6.35 | $5.62 | 147,895 | |
| $5.91 | -0.22 | -3.6% | $6.18 | $6.45 | $5.91 | 25,173 | |
| $6.13 | +0.18 | +3.0% | $6.08 | $6.495 | $6.08 | 33,024 | |
| $5.95 | -0.23 | -3.7% | $6.06 | $6.22 | $5.93 | 44,119 | |
| $6.18 | -0.40 | -6.1% | $6.611 | $6.611 | $6.025 | 27,606 | |
| $6.58 | -0.16 | -2.4% | $6.65 | $6.66 | $6.51 | 11,333 | |
| $6.74 | +0.18 | +2.7% | $6.69 | $6.76 | $6.53 | 37,620 | |
| $6.56 | -0.34 | -4.9% | $6.84 | $6.895 | $6.41 | 54,498 | |
| $6.90 | +0.015 | +0.2% | $6.89 | $7.00 | $6.85 | 7,273 | |
| $6.885 | -0.065 | -0.9% | $7.22 | $7.22 | $6.82 | 24,191 | |
| $6.95 | -0.27 | -3.7% | $7.22 | $7.35 | $6.95 | 12,944 | |
| $7.22 | -0.015 | -0.2% | $7.19 | $7.44 | $7.15 | 28,551 | |
| $7.235 | -0.005 | -0.1% | $7.15 | $7.30 | $7.13 | 5,201 | |
| $7.24 | +0.10 | +1.4% | $7.19 | $7.385 | $7.14 | 8,701 | |
| $7.14 | +0.10 | +1.4% | $7.04 | $7.23 | $7.04 | 4,130 | |
| $7.04 | -0.13 | -1.8% | $7.115 | $7.16 | $7.03 | 11,568 | |
| $7.17 | +0.05 | +0.7% | $7.05 | $7.17 | $7.05 | 9,505 | |
| $7.12 | -0.115 | -1.6% | $7.14 | $7.24 | $7.05 | 8,361 | |
| $7.235 | +0.105 | +1.5% | $7.03 | $7.38 | $7.03 | 11,584 | |
| $7.13 | +0.06 | +0.8% | $7.02 | $7.20 | $7.00 | 23,893 | |
| $7.07 | -0.02 | -0.3% | $7.09 | $7.20 | $6.92 | 69,053 | |
| $7.09 | -0.12 | -1.7% | $7.13 | $7.21 | $7.08 | 27,516 | |
| $7.21 | +0.03 | +0.4% | $7.305 | $7.399 | $7.10 | 11,683 | |
| $7.18 | -0.03 | -0.4% | $7.29 | $7.29 | $7.16 | 8,532 | |
| $7.21 | -0.24 | -3.2% | $7.46 | $7.46 | $7.21 | 17,341 | |
| $7.45 | +0.07 | +0.9% | $7.36 | $7.64 | $7.36 | 22,440 | |
| $7.38 | +0.02 | +0.3% | $7.32 | $7.67 | $7.32 | 33,973 | |
| $7.36 | -0.22 | -2.9% | $7.54 | $7.70 | $7.36 | 11,375 | |
| $7.58 | -0.24 | -3.1% | $7.66 | $7.70 | $7.50 | 7,839 | |
| $7.82 | +0.24 | +3.2% | $7.58 | $7.82 | $7.50 | 6,281 | |
| $7.58 | -0.08 | -1.0% | $7.59 | $7.64 | $7.58 | 3,011 | |
| $7.66 | -0.025 | -0.3% | $7.71 | $7.78 | $7.585 | 6,456 | |
| $7.685 | -0.005 | -0.1% | $7.73 | $7.79 | $7.67 | 3,882 | |
| $7.69 | +0.08 | +1.1% | $7.71 | $7.81 | $7.59 | 11,900 | |
| $7.61 | +0.03 | +0.4% | $7.56 | $7.69 | $7.54 | 2,601 | |
| $7.58 | -0.28 | -3.6% | $7.79 | $7.83 | $7.45 | 14,491 | |
| $7.86 | +0.03 | +0.4% | $7.685 | $7.875 | $7.60 | 8,285 | |
| $7.83 | +0.23 | +3.0% | $7.745 | $7.89 | $7.62 | 10,692 | |
| $7.60 | -0.21 | -2.7% | $7.75 | $7.88 | $7.60 | 5,377 | |
| $7.81 | +0.23 | +3.0% | $7.72 | $7.81 | $7.60 | 12,789 | |
| $7.58 | +0.15 | +2.0% | $7.40 | $7.88 | $7.40 | 9,204 | |
| $7.43 | +0.04 | +0.5% | $7.32 | $7.483 | $7.32 | 3,173 |
Splits
1 split · NASDAQ:TIL · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation |
- Ticker
- NASDAQ:TIL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 16, 2026
Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Latest news
Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nov 16, 2026
Closed $5.75 (-5.4%) on Nov 16, 2026
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026
Closed $7.38 (+1.5%) on Aug 14, 2026
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026
Closed $8.07 (+0.3%) on May 15, 2026
Instil Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 27, 2026
Closed $7.79 (-6.8%) on Mar 27, 2026
Instil Bio, Inc. on 6ix
- News releases
- 5 in the last 12 months · 54 in all · newest Nov 16, 2026 · oldest 2021
- Decks
- 6 decks · latest May 22, 2025
Where Instil Bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TIL · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TIL | BOATS | United States | USD |
| Tradegate:5GT0 | Tradegate | Germany | EUR |
| Frankfurt:5GT0 | Frankfurt | Germany | EUR |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $60.56M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.3×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.8×
- Beta vs S&P 500
- 0.57
Forecasts
1 hold · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 7.00 USD · Analysts' mean
- EPS, year to Dec 2026
- -2.23 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Sandeep Steve Laumas | Chief Financial Officer & Chief Business Officer |
Board
| Director | Role |
|---|---|
| Bronson Crouch | Chairman of the Board |
| George Matcham | Board Member |
| Gwendolyn Binder | Board Member |
| Neil Gibson | Board Member |
| R. Kent McGaughy | Board Member |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 16, 2026 · Before open | −5.4% |
| Q2 2026 | Aug 13, 2026 · After close | +1.5% |
| Q1 2026 | May 15, 2026 | +1.1% |
| Q4 2025 | Mar 27, 2026 · Before open | −6.8% |
| Q3 2025 | Nov 13, 2025 · Before open | −7.2% |
| Q2 2025 | Aug 13, 2025 · Before open | +0.5% |
| Q1 2025 | May 13, 2025 · Before open | −6.9% |
| Q4 2024 | Mar 19, 2025 · Before open | −5.3% |
| Q3 2024 | Nov 13, 2024 · Before open | −5.5% |
| Q2 2024 | Aug 13, 2024 · After close | +1.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 10, 2024 · Before open | +3.1% |
| Q4 2023 | Mar 21, 2024 · After close | −1.5% |
| Q3 2023 | Nov 13, 2023 · After close | −5.4% |
| Q2 2023 | Aug 14, 2023 · Before open | −5.2% |
| Q1 2023 | May 11, 2023 · Before open | −7.4% |
| Q4 2022 | Mar 31, 2023 · Before open | −0.4% |
| Q3 2022 | Nov 14, 2022 · After close | +1.2% |
| Q2 2022 | Aug 12, 2022 · Before open | +2.2% |
| Q1 2022 | May 16, 2022 · Before open | +8.7% |
| Q4 2021 | Mar 7, 2022 · Before open | −1.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (May 2025) | Investor deck | 18 slides | May 22, 2025 |
| Corporate Update (March 2025) | Corporate update | 9 slides | Mar 4, 2025 |
| Investor Presentation (September 2024) | Investor deck | 12 slides | Sep 16, 2024 |
| Investor Presentation (August 2024) | Investor deck | 15 slides | Aug 15, 2024 |
| Technical Presentation (June 2023) | Technical | 14 slides | June 2023 |
| Technical Presentation (April 2021) | Technical | 15 slides | April 2021 |
IPO
Priced at US$20.00 a share on Mar 18, 2021.
- Price
- US$20.00 a share
- Shares offered
- 16,000,000 shares of common stock
- Offering size
- US$320 million
- Underwriters' option
- Up to 2,400,000 more shares
- Underwriters
- MORGAN STANLEY, JEFFERIES, COWEN, TRUIST SECURITIES · In the order on the cover
- Shares delivered
- On or about Mar 23, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 12, 2021 |
| Filed publicly | Feb 26, 2021 |
| Amended twice | Newest Mar 18, 2021 |
| Shares registered with an exchange | Mar 15, 2021 |
| Declared effective by the SEC | Mar 18, 2021 |
| Final prospectus, with the price | Mar 22, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 22, 2021 |
| EFFECT · Notice that a registration is effective | Mar 18, 2021 |
| CERT · Exchange's certificate of listing | Mar 18, 2021 |
| S-1/A · Registration statement, amended | Mar 18, 2021 |
| CORRESP · Letter to the SEC | Mar 16, 2021 |
| CORRESP · Letter to the SEC | Mar 16, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 15, 2021 |
| CORRESP · Letter to the SEC | Mar 15, 2021 |
| S-1/A · Registration statement, amended | Mar 15, 2021 |
| UPLOAD · Letter from the SEC | Mar 12, 2021 |
All 18 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Mar 8, 2021 |
| CORRESP · Letter to the SEC | Feb 26, 2021 |
| S-1 · Registration statement | Feb 26, 2021 |
| UPLOAD · Letter from the SEC | Feb 24, 2021 |
| DRSLTR · Letter to the SEC with a draft | Feb 12, 2021 |
| DRS/A · Draft registration statement, amended | Feb 12, 2021 |
| UPLOAD · Letter from the SEC | Feb 5, 2021 |
| DRS · Draft registration statement | Jan 12, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Mar 22, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 138.0K | 0 |
| Cost of revenue | 534.0K | 3.61M | 4.76M | 5.99M | 2.75M | 20.0K | |
| Gross profit | -534.0K | -3.61M | -4.76M | -5.99M | -2.75M | 138.0K | -20.0K |
| Research and development | 24.7M | 11.8M | 39.6M | 141.1M | 107.3M | 19.4M | 4.03M |
| Selling, general and administrative | 27.2M | 44.2M | 47.6M | 62.2M | 48.3M | 14.4M | 2.56M |
| Operating income | -80.3M | -73.5M | -159.2M | -226.5M | -155.6M | -33.6M | -6.58M |
| Depreciation and amortization | 534.0K | 3.61M | 4.76M | 5.99M | 2.75M | 256.0K | 20.0K |
| EBITDA | -79.7M | -69.9M | -154.4M | -220.5M | -152.8M | -33.4M | -6.57M |
| Interest expense | 5.96M | 8.99M | 5.21M | 1.88M | 0 | 3.30M | 0 |
| Income before tax | -71.4M | -74.1M | -156.1M | -225.3M | -156.8M | -37.6M | -6.52M |
| Income tax | 0 | 0 | -2.07M | 39.0K | 151.0K | -68.0K | |
| Net income | -71.4M | -74.1M | -156.1M | -223.2M | -156.8M | -37.7M | -6.45M |
| Earnings per share, basic | -10.71 | -11.39 | -24.00 | -34.46 | -1.48 | -2.36 | -1.01 |
| Earnings per share, diluted | -10.71 | -11.39 | -24.00 | -34.46 | -1.48 | -2.36 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6.64M | 8.80M | 9.20M | 43.7M | 37.6M | 241.7M | 8.89M |
| Short-term investments | 69.5M | 104.5M | 141.2M | 217.2M | 416.5M | 0 | |
| Receivables | 848.0K | 2.62M | 8.14M | 3.17M | |||
| Inventory | 1.18M | ||||||
| Current assets | 192.4M | 124.5M | 160.8M | 269.4M | 464.0M | 246.1M | 9.29M |
| Property, plant and equipment | 126.0K | 129.4M | 138.7M | 196.9M | 122.0M | 55.3M | 190.0K |
| Goodwill | 0 | 5.72M | 5.72M | 0 | |||
| Total assets | 204.5M | 263.6M | 325.6M | 482.1M | 610.0M | 319.0M | 9.48M |
| Accounts payable | 779.0K | 659.0K | 1.21M | 2.36M | 5.57M | 3.50M | 979.0K |
| Current liabilities | 7.03M | 7.90M | 10.6M | 32.8M | 41.4M | 13.3M | 1.42M |
| Long-term debt | 84.8M | 84.2M | 81.4M | 72.3M | |||
| Total debt | 85.2M | 86.9M | 86.1M | 79.9M | |||
| Total liabilities | 91.8M | 94.1M | 99.8M | 118.5M | 54.8M | 26.6M | 1.42M |
| Shareholders' equity | 112.7M | 168.3M | 225.8M | 363.6M | 555.2M | -39.6M | 8.06M |
| Shares outstanding | 6.78M | 6.53M | 6.50M | 6.50M | 129.0M | 20.6M | 6.41M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -36.6M | -55.7M | -82.0M | -180.2M | -122.1M | -29.6M | -5.29M |
| Capital spending | -10.0M | 0 | -20.7M | -84.6M | -57.8M | -50.8M | -760.0K |
| Free cash flow | -36.6M | -55.7M | -102.7M | -264.8M | -180.0M | -80.4M | -6.05M |
| Cash from investing | 25.5M | 54.0M | 41.1M | 114.5M | -474.4M | -51.1M | -760.0K |
| Cash from financing | 7.29M | 1.75M | 8.08M | 71.9M | 393.2M | 313.0M | 14.9M |
| Share buybacks | 393.2M | ||||||
| Change in cash | -3.85M | 33.0K | -32.8M | 6.26M | -203.4M | 232.3M | 8.89M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 16, 2026 | Results | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 11, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | May 15, 2026 | Results | SEC |
| ARS · Annual report to shareholders | Apr 24, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 24, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 24, 2026 | Meeting notice | SEC |
| 8-K · Current report | Apr 3, 2026 | Current report | SEC |
| S-8 · Registration statement for employee plans | Mar 27, 2026 | Offer document | SEC |
| 10-K · Annual report | Mar 27, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 27, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 9, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jan 6, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2025 | Results | SEC |
| 4 · Change in ownership | Sep 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 10, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 12, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jul 31, 2025 | Current report | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 8-K · Current report | May 28, 2025 | Meeting outcome | SEC |
| 8-K · Current report | May 27, 2025 | Current report | SEC |
| 8-K · Current report | May 22, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 13, 2025 | Results | SEC |
| DEFR14A | May 2, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 14, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 14, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 14, 2025 | Meeting notice | SEC |
| 424B5 · Prospectus | Mar 31, 2025 | Offer document | SEC |
| 8-K · Current report | Mar 28, 2025 | Material contract | SEC |
| S-8 · Registration statement for employee plans | Mar 4, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 4, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 4, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 14, 2025 | Current report | SEC |
| 8-K · Current report | Dec 23, 2024 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Nov 22, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 19, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 19, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| S-3 · Registration statement | Nov 13, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Oct 25, 2024 | Big-stake notice | SEC |
| SC 13D/A · Big-stake notice, amended | Oct 22, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Sep 27, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Sep 27, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 23, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 16, 2024 | Current report | SEC |
| 8-K · Current report | Sep 6, 2024 | Current report | SEC |
| 8-K · Current report | Aug 15, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2024 | Results | SEC |
| 8-K · Current report | Aug 1, 2024 | Material contract | SEC |
| 8-K · Current report | Jul 11, 2024 | Material contract | SEC |
| 8-K · Current report | Jun 17, 2024 | Meeting outcome | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 10, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 10, 2024 | Results | SEC |
| ARS · Annual report to shareholders | Apr 26, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 26, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 26, 2024 | Meeting notice | SEC |
| 8-K · Current report | Apr 26, 2024 | Management or board change | SEC |
| SC 13G · Big-stake notice | Apr 2, 2024 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Mar 21, 2024 | Offer document | SEC |
| 10-K · Annual report | Mar 21, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 21, 2024 | Results | SEC |
| 8-K · Current report | Feb 14, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Feb 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 18, 2024 | Current report | SEC |
| 8-K · Current report | Jan 16, 2024 | Current report | SEC |
| 4 · Change in ownership | Jan 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 10, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 8, 2023 | Current report | SEC |
| 8-K · Current report | Nov 27, 2023 | Current report | SEC |
| 10-Q/A · Quarterly report, amended | Nov 13, 2023 | Quarterly report | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 14, 2023 | Results | SEC |
| 8-K · Current report | Jun 26, 2023 | Current report | SEC |
| 8-K · Current report | Jun 14, 2023 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2023 | Results | SEC |
| DEFR14A | Apr 28, 2023 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 24, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 24, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 24, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 14, 2023 | Meeting notice | SEC |
| SC 13G/A · Big-stake notice, amended | Apr 10, 2023 | Big-stake notice | SEC |
| 10-K · Annual report | Mar 31, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 31, 2023 | Results | SEC |
| 8-K · Current report | Mar 10, 2023 | Current report | SEC |
| 8-K · Current report | Feb 27, 2023 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 1, 2023 | Current report | SEC |
| 8-K · Current report | Jan 27, 2023 | Current report | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 9, 2023 | Current report | SEC |
| 8-K · Current report | Dec 8, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 14, 2022 | Results | SEC |
| 8-K · Current report | Nov 8, 2022 | Current report | SEC |
| 8-K · Current report | Oct 31, 2022 | Current report | SEC |
| 8-K · Current report | Oct 18, 2022 | Current report | SEC |
| 4 · Change in ownership | Sep 6, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 6, 2022 | Insider trade | SEC |
| 8-K · Current report | Sep 6, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 12, 2022 | Quarterly report | SEC |
| 8-K · Current report | Aug 12, 2022 | Results | SEC |
| SC 13G · Big-stake notice | Jun 22, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Jun 13, 2022 | Material contract | SEC |
| 8-K · Current report | May 27, 2022 | Current report | SEC |
| 4 · Change in ownership | May 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2022 | Insider trade | SEC |
| 4 · Change in ownership | May 25, 2022 | Insider trade | SEC |
| 8-K · Current report | May 20, 2022 | Meeting outcome | SEC |
| 8-K · Current report | May 18, 2022 | Current report | SEC |
| 8-K · Current report | May 16, 2022 | Results | SEC |
| 10-Q · Quarterly report | May 16, 2022 | Quarterly report | SEC |
| 3 · Initial statement of ownership | May 3, 2022 | Insider trade | SEC |
| S-3ASR · Registration statement | Apr 1, 2022 | Offer document | SEC |
| DEFA14A · Additional proxy material | Mar 30, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 30, 2022 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 17, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 7, 2022 | Insider trade | SEC |
| 10-K · Annual report | Mar 7, 2022 | Annual report | SEC |
| 8-K · Current report | Mar 7, 2022 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Dec 17, 2021 | Management or board change | SEC |
| 8-K · Current report | Nov 15, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| 8-K · Current report | Nov 15, 2021 | Current report | SEC |
| SC 13G · Big-stake notice | Nov 10, 2021 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 8, 2021 | Insider trade | SEC |
| 8-K · Current report | Sep 16, 2021 | Current report | SEC |
| 4 · Change in ownership | Sep 13, 2021 | Insider trade | SEC |
| 8-K · Current report | Sep 13, 2021 | Current report | SEC |
| 10-Q · Quarterly report | Aug 12, 2021 | Quarterly report | SEC |
| 8-K · Current report | Aug 12, 2021 | Results | SEC |
| 4 · Change in ownership | May 13, 2021 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2021 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2021 | Insider trade | SEC |
| 4 · Change in ownership | May 13, 2021 | Insider trade | SEC |
| 8-K · Current report | May 13, 2021 | Results | SEC |
| 10-Q · Quarterly report | May 13, 2021 | Quarterly report | SEC |
| 8-K · Current report | Apr 27, 2021 | Current report | SEC |
| S-8 · Registration statement for employee plans | Apr 20, 2021 | Offer document | SEC |
| SC 13G · Big-stake notice | Apr 15, 2021 | Big-stake notice | SEC |
| 8-K · Current report | Apr 13, 2021 | Current report | SEC |
| SC 13D · Big-stake notice | Apr 5, 2021 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Apr 1, 2021 | Big-stake notice | SEC |
| SC 13D · Big-stake notice | Apr 1, 2021 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Mar 25, 2021 | Insider trade | SEC |
| 8-K · Current report | Mar 23, 2021 | Current report | SEC |
| 4 · Change in ownership | Mar 22, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Mar 22, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Mar 22, 2021 | Insider trade | SEC |
This page holds 200 of 250 filings. Open Filings
Cap table
Built by 6ix from Instil Bio, Inc.’s releases · as of Aug 11, 2026
- Common shares
- 6,781,976
- Fully diluted
- 6,781,976
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 6,781,976 | Aug 11, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 11, 2026 | 6,781,976 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John M. Maraganore Other companies: City Therapeutics, Inc. (Executive Chair · Since at least Oct 19, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Jan 29, 2026); Rapport Therapeutics, Inc. (Venture Partner, ARCH Venture Partners and Atlas Ventures · Since at least Jun 6, 2024); Kymera Therapeutics, Inc. (Director · Since at least Jan 17, 2022); Beam Therapeutics Inc. (Board Member · Since at least Nov 5, 2021); Alnylam Pharmaceuticals, Inc. (Director · Since at least May 12, 2006); ProKidney Corp. (Director · Jul 11, 2022 – Jun 29, 2023 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Dec 31, 2022 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Sep 14, 2017 · Past); Regulus Therapeutics Inc (Director · Oct 4, 2012 – Oct 10, 2012 · Past) | Director · Jun 11, 2025 – Nov 4, 2026 · Past |
| Timothy L Moore Other companies: BioLife Solutions, Inc. (Director · Since at least Sep 1, 2022); Cerus Corporation (Director · Since at least Sep 5, 2018); Allogene Therapeutics, Inc. (Chief Technical Officer · Apr 24, 2023 – Feb 3, 2025 · Past); Kite Pharma Inc (EVP, Technical Operations · Mar 15, 2016 – Oct 3, 2017 · Past) | Chief Operating Officer · Sep 6, 2022 – Sep 6, 2022 · Past |
| Jack Nielsen Other companies: Aligos Therapeutics, Inc. (Director · Jun 23, 2022 – Feb 27, 2024 · Past); ALX Oncology Holdings Inc. (Director · Jun 15, 2022 – Jun 20, 2023 · Past); Harmony Biosciences Holdings, Inc. (Director · Mar 30, 2022 – May 29, 2024 · Past) | Director · May 20, 2022 – Jun 14, 2023 · Past |
| Neil Gibson Other companies: Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Jun 1, 2023 · Past); Regulus Therapeutics Inc (Chief Scientific Officer · Oct 4, 2012 – Jan 28, 2015 · Past) | Board Member · Since at least Mar 18, 2021 |
| R Kent McGaughy Jr Other companies: Apollo Endosurgery Inc (Director · Dec 29, 2016 – Apr 4, 2023 · Past); Reata Pharmaceuticals Inc (Director · May 25, 2016 – Sep 26, 2023 · Past) | Director · Since at least Mar 18, 2021 |
| Sandeep Steve Laumas Other companies: Unicycive Therapeutics, Inc. (Director · Since at least Jul 12, 2021); BioXcel Therapeutics, Inc. (Director · Since at least Mar 7, 2018) | Chief Financial Officer & Chief Business Officer · Since at least Mar 18, 2021 |
| Gwendolyn Binder Other companies: Cabaletta Bio, Inc. (President, Science & Technology · Since at least Oct 24, 2019) | Board Member · Since at least Mar 18, 2021 |
| Bronson Crouch | Chairman of the Board · Since at least Mar 18, 2021 |
| George Matcham | Board Member · Since at least Mar 18, 2021 |
| Jamie Freedman | Chief Medical Officer · Jun 2, 2025 – Nov 4, 2026 · Past |
All 11 people
| Person | Seat |
|---|---|
| R. Kent McGaughy | Board Member · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Instil Bio, Inc.